AR and neoplasm: Clioquinol, a therapeutic agent for Alzheimer's disease, is able to target tumor proteasome in vivo in a copper-dependent manner, resulting in formation of an active AR inhibitor and apoptosis inducer that is responsible for its observed antiprostate tumor effect [10].